TAUNS Laboratories (197A) · InitiativeReframed
Developing the prevention and pre-illness markets using the Home Test Database
First written in FY2024. 1 of 2 entries say "Reframed", first in FY2026. Latest entry: FY2026.
2entries
3years
0from disclosures
How it moved
Same theme, other companies
Development of Preventive and Pre-Disease POCT Using Home-Test DataA theme 1 companies write about · 0 as a headwind · 1 as a tailwind
No other company in this theme has enough history to compare yet.
Full recordFilings, disclosures and news, newest first
- FY2026ReframedAnnual report
「We will accumulate diverse medical data, including biobank specimens, testing data and medical imaging data, in a form that can be used appropriately under proper management in compliance with relevant laws and regulations. We will also develop the computing resources, algorithms and data operating environment required for AI analysis and other purposes.」
The focus of the description shifted from the previous concept of home testing and a specimen database in collaboration with medical institutions to a data infrastructure concept encompassing biobanks, testing and imaging data, and an AI analysis environment. - FY2024First statedAnnual report
「We are preparing to use home tests based on minimally invasive samples, analyze the health information obtained from them, and build sample databases in collaboration with medical institutions.」
The concept is to use accumulated and analyzed sample data to discover new biomarkers and develop POCT products for prevention and pre-disease detection.